Ajay Goel Selected Research

Enzymes

1/2022	RNA editing facilitates the enhanced production of neoantigens during the simultaneous administration of oxaliplatin and radiotherapy in colorectal cancer.
12/2018	Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer.
3/2016	Sirt1 Is Required for Resveratrol-Mediated Chemopreventive Effects in Colorectal Cancer Cells.
10/2014	Early detection of metachronous bile duct cancer in Lynch syndrome: report of a case.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ajay Goel Research Topics

Disease

197	Neoplasms (Cancer) 02/2024 - 01/2003
134	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 01/2003
38	Neoplasm Metastasis (Metastasis) 01/2024 - 12/2009
33	Carcinogenesis 11/2023 - 12/2004
32	Microsatellite Instability 01/2023 - 01/2003
25	Colonic Neoplasms (Colon Cancer) 01/2022 - 01/2003
23	Adenocarcinoma 10/2023 - 01/2015
22	Stomach Neoplasms (Stomach Cancer) 01/2024 - 08/2006
13	Adenoma (Adenomas) 01/2022 - 03/2008
11	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 02/2024 - 11/2010
11	Lymphatic Metastasis 01/2023 - 11/2013
11	Chromosomal Instability (Chromosome Stability) 12/2020 - 11/2003
9	Polyps 01/2022 - 02/2003
8	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 05/2007
8	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 05/2015 - 06/2008
7	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 02/2008
7	Adenomatous Polyps 11/2019 - 12/2007
6	Inflammation (Inflammations) 05/2023 - 09/2011
6	Body Weight (Weight, Body) 01/2011 - 10/2005
5	Esophageal Squamous Cell Carcinoma 11/2022 - 01/2018
5	Colitis 01/2021 - 10/2015
5	Infections 01/2017 - 10/2008
5	Carcinoma (Carcinomatosis) 01/2015 - 01/2011
4	Ulcerative Colitis 05/2023 - 02/2008
4	Rectal Neoplasms (Rectal Cancer) 01/2021 - 07/2015
4	Disease Progression 01/2018 - 04/2015
3	Poliomyelitis (Polio) 07/2021 - 04/2020
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2019
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 05/2005
3	Arthritis (Polyarthritis) 04/2010 - 02/2003
2	Cholangiocarcinoma 01/2022 - 07/2019

Drug/Important Bio-Agent (IBA)

104	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2006
61	MicroRNAs (MicroRNA)IBA 02/2024 - 07/2010
30	Calcibiotic Root Canal SealerIBA 01/2022 - 01/2004
26	Proteins (Proteins, Gene)FDA Link 02/2021 - 01/2003
22	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 08/2003
21	CurcuminIBA 03/2023 - 02/2008
20	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 02/2004
15	RNA (Ribonucleic Acid)IBA 05/2023 - 07/2010
10	Long Noncoding RNAIBA 01/2022 - 12/2014
9	Messenger RNA (mRNA)IBA 01/2023 - 12/2009
7	Untranslated RNA (Noncoding RNA)IBA 02/2022 - 12/2014
7	Proanthocyanidins (Procyanidins)IBA 01/2022 - 01/2018
7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 01/2003
7	Tumor Viral Antigens (Large T Antigen)IBA 07/2014 - 11/2003
6	Tumor Biomarkers (Tumor Markers)IBA 02/2024 - 11/2014
6	Gemcitabine FDA Link 01/2023 - 01/2010
6	hydrogen sulfite (bisulfite)IBA 01/2022 - 06/2008
6	Indicators and Reagents (Reagents)IBA 04/2020 - 08/2003
6	ResveratrolIBA 01/2019 - 11/2015
6	ZincIBA 01/2011 - 10/2005
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 01/2010
5	AntibodiesIBA 12/2021 - 06/2015
5	Small Interfering RNA (siRNA)IBA 01/2021 - 12/2014
5	VaccinesIBA 04/2020 - 07/2011
5	Drinking WaterIBA 01/2011 - 10/2005
4	Cell-Free Nucleic AcidsIBA 01/2024 - 12/2014
4	Circular RNAIBA 10/2023 - 07/2017
4	6-methyladenineIBA 01/2023 - 01/2019
4	BerberineIBA 09/2022 - 01/2022
4	EnzymesIBA 01/2022 - 10/2014
4	Histones (Histone)IBA 01/2021 - 11/2005
4	Transcription Factors (Transcription Factor)IBA 01/2019 - 06/2008
4	VimentinIBA 07/2018 - 06/2012
4	Chlorpyrifos (Lorsban)IBA 02/2007 - 10/2005
3	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2019
3	AntigensIBA 01/2024 - 01/2019
3	Adenosine (Adenocard)FDA LinkGeneric 05/2023 - 01/2018
3	Inosine FDA Link 05/2023 - 01/2018
3	N-methyladenosineIBA 11/2022 - 01/2019
3	Dextrans (Dextran)FDA Link 01/2022 - 01/2017
3	AzoxymethaneIBA 01/2022 - 01/2017
3	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2022 - 01/2017
3	Cyclin D1IBA 01/2021 - 05/2009
3	Dextran SulfateIBA 01/2021 - 11/2017
3	CateninsIBA 10/2020 - 06/2015
3	PolyphenolsIBA 01/2019 - 12/2010
3	Cadherins (E-Cadherin)IBA 07/2018 - 06/2012
3	TeaIBA 12/2017 - 12/2010
3	boswellic acidIBA 05/2015 - 05/2012
3	beta CateninIBA 05/2009 - 11/2003
2	NivolumabIBA 01/2024 - 01/2019
2	Circulating Tumor DNAIBA 01/2024 - 01/2020
2	InterferonsIBA 05/2023 - 02/2021
2	A-Form DNA (A-DNA)IBA 01/2023 - 06/2008
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2022 - 01/2010
2	Therapeutic UsesIBA 01/2022 - 01/2019
2	MelatoninIBA 01/2022 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 12/2021 - 01/2019

Therapy/Procedure

30	Therapeutics 01/2024 - 09/2008
27	Drug Therapy (Chemotherapy) 01/2024 - 08/2003
11	Chemoprevention 10/2020 - 05/2005
6	Neoadjuvant Therapy 11/2022 - 10/2019
5	Immunotherapy 01/2024 - 06/2015
5	Adjuvant Chemotherapy 01/2023 - 04/2011
5	Precision Medicine 01/2022 - 01/2013
4	Radiotherapy 01/2024 - 01/2010
3	Complementary Therapies (Alternative Medicine) 01/2022 - 12/2017
2	Lymph Node Excision (Lymph Node Dissection) 01/2023 - 12/2013
2	Hepatectomy 01/2022 - 01/2022